The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOsirium Tech Regulatory News (OSI)

  • This share is currently suspended. It was suspended at a price of 2.20

Share Price Information for Osirium Tech (OSI)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2.20
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 0.00 (0.00%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 0.00
OSI Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Total Voting Rights

31 Oct 2019 10:48

RNS Number : 8081R
Osirium Technologies PLC
31 October 2019
 

31 October 2019

Osirium Technologies plc

("Osirium" or the "Company")

 

Total Voting Rights

For the purposes of DTR5.6.1R of the Transparency Directive, the Company notifies the market of the following:

 

As of 31 October 2019, the Company's issued and fully paid share capital consists of 19,495,655 ordinary shares ("Ordinary Shares") with nominal value of 1 pence each, with one voting right per share. The Company does not hold any Ordinary Shares in Treasury. The total number of voting rights in the Company is therefore 19,495,655.

 

The above figure of 19,495,655 should be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company, under the Disclosure and Transparency Rules.

 

For further information, please contact:

 

Osirium Technologies plc

+44 (0) 118 324 2444

David Guyatt, Chief Executive Officer

Rupert Hutton, Chief Financial Officer

Martin Kay, Company Secretary

www.osirium.com

Stifel (Nomad and Joint Broker)

+44 (0) 20 7710 7600

Fred Walsh / Neil Shah

Alma (Financial PR)

+44 (0) 20 3405 0205

Hilary Buchanan / Josh Royston / Kieren Breheny

 

 

About Osirium

 

Osirium Technologies plc (AIM: OSI) operates in one of the fastest growing parts of the cybersecurity market and is a leading vendor of Privileged Access Security solutions. Osirium's cloud-based products protect critical IT assets, infrastructure and devices by preventing targeted cyber-attacks from directly accessing Privileged Accounts, removing unnecessary access and powers of Privileged Account users, deterring legitimate Privileged Account users from abusing their roles and containing the effects of a breach if one does happen. 

 

Osirium has defined and delivered what the Directors view as the next generation Privileged Access Management solution. Built on Robotic Automation technology, Osirium's Privileged Task Management module further strengthens Privileged Account security by minimising the cyber-attack surface and delivering an impressive return on investment benefits for customers. Building on Osirium's Privileged Task Management module, in May 2019 Osirium launched "Opus", providing a highly-flexible platform for automating essential IT processes to set a new benchmark in Privileged Process Automation.

 

Founded in 2008 and with its headquarters in Reading, UK, the Group was admitted to AIM in April 2016. For further information please visit www.osirium.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TVREAEEFDLPNFFF
Date   Source Headline
15th Oct 20207:00 amRNSContract win with leading healthcare provider
8th Oct 20207:00 amRNSCompetitive contract win with major UK Retailer
29th Sep 20207:00 amRNSInterim Results
21st Sep 20207:00 amRNSNotice of Results
16th Jun 202012:00 pmRNSResult of AGM
15th May 20207:00 amRNSFinal Results
8th Apr 20207:00 amRNSCOVID-19 Update and Contract Renewal
17th Mar 20207:00 amRNSContract win with major regional Ambulance Service
24th Feb 20203:46 pmRNSHolding(s) in Company
20th Feb 20207:00 amRNSContract win with major regional NHS Trust
20th Feb 20207:00 amRNSContract win with major regional NHS Trust
14th Jan 20207:00 amRNSTrading Update
11th Dec 20197:00 amRNSLaunch of Privileged Endpoint Manager solution
14th Nov 20195:25 pmRNSHolding(s) in Company
31st Oct 201910:48 amRNSTotal Voting Rights
30th Oct 201911:35 amRNSHolding(s) in Company
29th Oct 201912:09 pmRNSHolding(s) in Company
22nd Oct 20197:00 amRNSResult of fundraise
21st Oct 20197:00 amRNSProposed fundraise
10th Oct 20197:00 amRNSNew customer and upsell contract wins
23rd Sep 20197:00 amRNSSubstantial contract win
18th Sep 20197:00 amRNSHalf Year Report
10th Sep 20191:27 pmRNSNotice of Results
14th Aug 20197:00 amRNSFirst contract win for Opus
7th Aug 20197:00 amRNSContract wins
8th Jul 20197:00 amRNSTrading update
13th Jun 201912:07 pmRNSResult of AGM
6th Jun 20197:00 amRNSContract win
4th Jun 20197:00 amRNSInfosecurity Europe 2019
29th May 20197:00 amRNSHolding(s) in Company
17th May 20197:00 amRNSContract Extension
8th May 20197:00 amRNSFinal Results
1st May 20197:00 amRNSLaunch of secure IT Process Automation solution
29th Apr 20197:00 amRNSNotice of Final Results
18th Apr 20194:05 pmRNSHolding(s) in Company
22nd Mar 20194:30 pmRNSHolding(s) in Company
27th Feb 20197:00 amRNSContract wins
12th Feb 20197:00 amRNSContract win
14th Jan 20197:00 amRNSTrading Update
9th Jan 20191:59 pmRNSHolding(s) in Company
8th Jan 20197:00 amRNSContract win with major Business Energy player
19th Dec 20187:00 amRNSContract win with Financial Services provider
5th Oct 20187:00 amRNSGrant of options and PDMR dealings
25th Sep 20187:00 amRNSInterim results
21st Sep 20187:00 amRNSContract win with UK Fashion and Homeware Retailer
19th Sep 20187:00 amRNSStrategic Technology Partnership with RazorSecure
6th Aug 20187:00 amRNSNotice of Interim Results
24th May 201811:31 amRNSResult of AGM
14th May 201810:39 amRNSHolding(s) in Company
24th Apr 20187:00 amRNSFinal Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.